Modulation of microbiota by traditional Chinese medicine in chronic inflammatory airway disease: a systematic review and meta-analysis of animal studies
- 1National Regional TCM (Pulmonary Disease) Diagnostic and Treatment Center, The First Affiliated Hospital of Henan University of Chinese Medicine , ,
Abstract
Background: A growing number of studies have indicated that traditional Chinese medicine (TCM) can regulate microbiota in chronic inflammatory airway disease (CIAD). Nevertheless, no systematic review or integrated analysis has summarized relevant evidence to date, limiting the clinical application of TCM in this field.
Methods: This study followed the PRISMA reporting guidelines. We systematically searched PubMed, EMBASE, the Cochrane Library and Web of Science for animal studies published from January 1, 2006 to January 5, 2026 exploring the effects of TCM on microbiota in CIAD. Microbial diversity indices and abundance data were extracted. Meta-analysis was performed using R version 4.5.0 with the meta for package (version 5.0.1), and risk of bias was assessed using the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) tool.
Results: A total of 25 studies published from 2016 to 2025 were included, 20 of which were enrolled into the meta-analysis. No statistically significant overall effect of TCM on the examined gut or airway alpha-diversity indices was identified after re-analysis using REML random-effects models with Hartung–Knapp adjustment. Several pooled estimates showed substantial heterogeneity and sensitivity to individual-study omission. Most included studies reported differences in beta diversity between model and TCM groups. Changes in airway and gut microbial relative abundance were heterogeneous across studies. High or unclear risk of bias was identified in most SYRCLE domains for the included studies.
Conclusion: Current preclinical evidence suggests that TCM may be associated with changes in airway and gut microbiota in CIAD animal models. However, the updated quantitative analyses did not demonstrate statistically significant overall effects on the alpha-diversity indices examined, and evidence concerning airway microbiota and microbial relative abundance remains heterogeneous. These findings should not be interpreted as evidence of microbiota restoration or therapeutic mechanisms. Well-designed studies with more standardized methodologies are warranted to clarify the impact of TCM on lung–gut axis microecology.
Systematic Review Registration: https://www.crd.york.ac.uk/prospero/ , identifier PROSPERO CRD420261385384.
Related
- Evaluating traditional Chinese medicine modulation of the gut microbiota–bile acid axis in metabolic and inflammatory diseases: mechanistic evidence and translational priorities
- Microbiota–host crosstalk in ulcerative colitis: mechanistic evidence and translational prospects for traditional Chinese medicine
- Targeting the Microbiota–Metabolism–Immunity Axis: Active Components of Traditional Chinese Medicine in Colitis-Associated Colorectal Cancer
- Characteristics of Gut Microbiota in Patients with Polycystic Ovary Syndrome Across Different Traditional Chinese Medicine Syndrome Types.
- Tautomeric Diversity in the Baicalein Radical Cation: EPR Fingerprints of a Traditional Chinese Medicine Antioxidant
BibTeX
@article{sai2026modulation,
title = {{Modulation of microbiota by traditional Chinese medicine in chronic inflammatory airway disease: a systematic review and meta-analysis of animal studies}},
author = {Junting Sai and Haixia Li and Liu Chun and Weike Li and Dongmin Song and Mingyang Yi and Zhiwan Wang},
journal = {Frontiers in immunology},
year = {2026},
month = sep,
doi = {10.3389/fimmu.2026.1904457},
url = {https://europepmc.org/article/PMC/PMC13661446},
note = {CC BY},
}
RIS
TY - JOUR
TI - Modulation of microbiota by traditional Chinese medicine in chronic inflammatory airway disease: a systematic review and meta-analysis of animal studies
AU - Junting Sai
AU - Haixia Li
AU - Liu Chun
AU - Weike Li
AU - Dongmin Song
AU - Mingyang Yi
AU - Zhiwan Wang
PY - 2026
DA - 2026/09/30
JO - Frontiers in immunology
DO - 10.3389/fimmu.2026.1904457
UR - https://europepmc.org/article/PMC/PMC13661446
AB - Background: A growing number of studies have indicated that traditional Chinese medicine (TCM) can regulate microbiota in chronic inflammatory airway disease (CIAD). Nevertheless, no systematic review or integrated analysis has summarized relevant evidence to date, limiting the clinical application of TCM in this field. Methods: This study followed the PRISMA reporting guidelines. We systematically searched PubMed, EMBASE, the Cochrane Library and Web of Science for animal studies published from January 1, 2006 to January 5, 2026 exploring the effects of TCM on microbiota in CIAD. Microbial diversity indices and abundance data were extracted. Meta-analysis was performed using R version 4.5.0 with the meta for package (version 5.0.1), and risk of bias was assessed using the Systematic Review Centre for Laboratory Animal Experimentation (SYRCLE) tool. Results: A total of 25 studies published from 2016 to 2025 were included, 20 of which were enrolled into the meta-analysis. No statistically significant overall effect of TCM on the examined gut or airway alpha-diversity indices was identified after re-analysis using REML random-effects models with Hartung–Knapp adjustment. Several pooled estimates showed substantial heterogeneity and sensitivity to individual-study omission. Most included studies reported differences in beta diversity between model and TCM groups. Changes in airway and gut microbial relative abundance were heterogeneous across studies. High or unclear risk of bias was identified in most SYRCLE domains for the included studies. Conclusion: Current preclinical evidence suggests that TCM may be associated with changes in airway and gut microbiota in CIAD animal models. However, the updated quantitative analyses did not demonstrate statistically significant overall effects on the alpha-diversity indices examined, and evidence concerning airway microbiota and microbial relative abundance remains heterogeneous. These findings should not be interpreted as evidence of microbiota restoration or therapeutic mechanisms. Well-designed studies with more standardized methodologies are warranted to clarify the impact of TCM on lung–gut axis microecology. Systematic Review Registration: https://www.crd.york.ac.uk/prospero/ , identifier PROSPERO CRD420261385384.
SN - 1664-3224
ER -